gb_flag germany_flag japan_flag korea_flag china_flag
Back to Team

Antony Latham

Partner, Patent Attorney London
Profile of Antony Latham

I joined D Young & Co in 2012 and was appointed partner in 2022. I am a UK and European patent attorney specialising in pharmaceuticals, veterinary medicine and life sciences, with particular expertise in peptide therapeutics, RNA modalities, vaccines, antibodies and enzymes. I am particularly passionate about developing robust and creative patent strategies for complex and high-value technologies.

I work closely with clients to understand both their science and their commercial objectives. This enables me to deliver clear, pragmatic advice across the full patent lifecycle, including in challenging prosecution and contentious scenarios.

I advise a diverse client base, including several of the world’s leading pharmaceutical companies, on patent drafting, prosecution, opposition and defence. I have extensive experience representing clients in adversarial proceedings before the European Patent Office (EPO) Opposition Divisions and Boards of Appeal. My practice also includes due diligence and freedom-to-operate (FTO) analyses, often in the context of transactions or product launch planning. I also have specialist experience in obtaining supplementary protection certificates (SPCs) and paediatric extensions.  

I am pleased to have been recognised in the JUVE Patent Top 10 patent cases of the year 2025 in relation to the defence of a blockbuster pharmaceutical product. I regularly lecture on intellectual property law and have presented at international bioscience and IP conferences.

I have signed the IP Inclusive Senior Leaders' Pledge to demonstrate my personal commitment to improving diversity and inclusion (D&I) in our firm.

Awards

Ranked as a 'notable practitioner' by IPSTARS 2021.

Qualifications

  • BA (Hons) in Natural Sciences (Biological), Queens' College, University of Cambridge.
  • Foundation Scholarship for high achievement, University of Cambridge.
  • PhD in Biochemistry and Molecular Biology, University of Leeds.
  • Certificate in Intellectual Property Law, Queen Mary, University of London.
  • Certificate in IP Litigation.
  • Chartered Patent Attorney 2016.
  • European Patent Attorney 2016.
  • Registered representative before the Unified Patent Court (UPC) 2023.

Memberships

  • Chartered Institute of Patent Attorneys (CIPA).
  • European Patent Institute (epi).

Publications

  • Latham AM et al. In silico design and biological evaluation of a dual specificity kinase inhibitor targeting cell cycle progression and angiogenesis. PLoS One 9: e110997 (2014).
  • Fearnley GW et al. VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions. Mol. Biol. Cell 25: 2509-21 (2014).
  • Latham AM et al. Indolinones and anilinophthalazines differentially target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells. Br. J. Pharmacol. 165: 245-59 (2012).
Antony Latham is super smart and fun to work with. He works hard, is always very well prepared and diligent in his follow up and communicates clear and to the point, no matter whether this is in internal meetings or when presenting our case at the EPO.
Legal 500
Anthony Latham stands out not only as a skilled lawyer but also as a doctor with remarkable talents in both legal and scientific domains.
Legal 500
I can honestly say that it is only because of Antony Latham’s knowledge of both legal and scientific matters, and his ability to take initiative that I could protect my decade-long intellectual property.
Legal 500
Rising Star 2019/20.
IP Stars (Managing IP)
Rising Star 2018/19.
IP Stars (Managing IP)
[Antony Latham's] comprehensive understanding of the intricate nuances of intellectual property law, coupled with his deep scientific knowledge, have been instrumental in [his clients'] patent endeavours.
Legal 500